nodes	percent_of_prediction	percent_of_DWPC	metapath
Glycopyrrolate—CHRM3—ureter—kidney cancer	0.00677	0.865	CbGeAlD
Glycopyrrolate—Body temperature increased—Sorafenib—kidney cancer	0.00103	0.00104	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Sunitinib—kidney cancer	0.00103	0.00104	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Vincristine—kidney cancer	0.00103	0.00104	CcSEcCtD
Glycopyrrolate—Pruritus—Erlotinib—kidney cancer	0.00103	0.00104	CcSEcCtD
Glycopyrrolate—Fatigue—Dactinomycin—kidney cancer	0.00103	0.00103	CcSEcCtD
Glycopyrrolate—Epistaxis—Capecitabine—kidney cancer	0.00103	0.00103	CcSEcCtD
Glycopyrrolate—Flatulence—Paclitaxel—kidney cancer	0.00102	0.00103	CcSEcCtD
Glycopyrrolate—Pain—Dactinomycin—kidney cancer	0.00102	0.00103	CcSEcCtD
Glycopyrrolate—Tension—Paclitaxel—kidney cancer	0.00102	0.00102	CcSEcCtD
Glycopyrrolate—Dysgeusia—Paclitaxel—kidney cancer	0.00101	0.00102	CcSEcCtD
Glycopyrrolate—Oedema—Gemcitabine—kidney cancer	0.00101	0.00102	CcSEcCtD
Glycopyrrolate—Anaphylactic shock—Gemcitabine—kidney cancer	0.00101	0.00102	CcSEcCtD
Glycopyrrolate—Nervousness—Paclitaxel—kidney cancer	0.00101	0.00101	CcSEcCtD
Glycopyrrolate—Infection—Gemcitabine—kidney cancer	0.001	0.00101	CcSEcCtD
Glycopyrrolate—Dizziness—Vinblastine—kidney cancer	0.001	0.00101	CcSEcCtD
Glycopyrrolate—Dizziness—Everolimus—kidney cancer	0.000996	0.001	CcSEcCtD
Glycopyrrolate—Abdominal pain—Sunitinib—kidney cancer	0.000995	0.001	CcSEcCtD
Glycopyrrolate—Body temperature increased—Sunitinib—kidney cancer	0.000995	0.001	CcSEcCtD
Glycopyrrolate—Hypotension—Vincristine—kidney cancer	0.000994	0.001	CcSEcCtD
Glycopyrrolate—Nervous system disorder—Gemcitabine—kidney cancer	0.00099	0.000998	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Dactinomycin—kidney cancer	0.000982	0.000989	CcSEcCtD
Glycopyrrolate—Skin disorder—Gemcitabine—kidney cancer	0.000981	0.000988	CcSEcCtD
Glycopyrrolate—Rhinitis—Capecitabine—kidney cancer	0.000979	0.000987	CcSEcCtD
Glycopyrrolate—Vision blurred—Paclitaxel—kidney cancer	0.000976	0.000984	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Gemcitabine—kidney cancer	0.000976	0.000984	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000974	0.000982	CcSEcCtD
Glycopyrrolate—Hypoaesthesia—Capecitabine—kidney cancer	0.000971	0.000979	CcSEcCtD
Glycopyrrolate—Urinary tract disorder—Capecitabine—kidney cancer	0.000964	0.000972	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Sorafenib—kidney cancer	0.000963	0.000971	CcSEcCtD
Glycopyrrolate—Insomnia—Vincristine—kidney cancer	0.000962	0.00097	CcSEcCtD
Glycopyrrolate—Vomiting—Vinblastine—kidney cancer	0.000961	0.000969	CcSEcCtD
Glycopyrrolate—Dizziness—Erlotinib—kidney cancer	0.000961	0.000969	CcSEcCtD
Glycopyrrolate—Connective tissue disorder—Capecitabine—kidney cancer	0.000959	0.000967	CcSEcCtD
Glycopyrrolate—Vomiting—Everolimus—kidney cancer	0.000958	0.000965	CcSEcCtD
Glycopyrrolate—Urethral disorder—Capecitabine—kidney cancer	0.000957	0.000965	CcSEcCtD
Glycopyrrolate—Agitation—Paclitaxel—kidney cancer	0.000952	0.000959	CcSEcCtD
Glycopyrrolate—Rash—Everolimus—kidney cancer	0.00095	0.000957	CcSEcCtD
Glycopyrrolate—Dermatitis—Everolimus—kidney cancer	0.000949	0.000956	CcSEcCtD
Glycopyrrolate—Headache—Vinblastine—kidney cancer	0.000947	0.000955	CcSEcCtD
Glycopyrrolate—Headache—Everolimus—kidney cancer	0.000944	0.000951	CcSEcCtD
Glycopyrrolate—Hypotension—Gemcitabine—kidney cancer	0.000943	0.000951	CcSEcCtD
Glycopyrrolate—Abdominal pain—Dactinomycin—kidney cancer	0.000942	0.000949	CcSEcCtD
Glycopyrrolate—Body temperature increased—Dactinomycin—kidney cancer	0.000942	0.000949	CcSEcCtD
Glycopyrrolate—Anaphylactoid reaction—Doxorubicin—kidney cancer	0.00094	0.000947	CcSEcCtD
Glycopyrrolate—Asthenia—Sorafenib—kidney cancer	0.000938	0.000946	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Sunitinib—kidney cancer	0.000927	0.000934	CcSEcCtD
Glycopyrrolate—Pruritus—Sorafenib—kidney cancer	0.000925	0.000932	CcSEcCtD
Glycopyrrolate—Vomiting—Erlotinib—kidney cancer	0.000924	0.000931	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Vincristine—kidney cancer	0.000919	0.000926	CcSEcCtD
Glycopyrrolate—Fatigue—Vincristine—kidney cancer	0.000917	0.000925	CcSEcCtD
Glycopyrrolate—Rash—Erlotinib—kidney cancer	0.000916	0.000924	CcSEcCtD
Glycopyrrolate—Dermatitis—Erlotinib—kidney cancer	0.000916	0.000923	CcSEcCtD
Glycopyrrolate—Palpitations—Paclitaxel—kidney cancer	0.000915	0.000922	CcSEcCtD
Glycopyrrolate—Insomnia—Gemcitabine—kidney cancer	0.000913	0.00092	CcSEcCtD
Glycopyrrolate—Headache—Erlotinib—kidney cancer	0.00091	0.000918	CcSEcCtD
Glycopyrrolate—Pain—Vincristine—kidney cancer	0.00091	0.000917	CcSEcCtD
Glycopyrrolate—Constipation—Vincristine—kidney cancer	0.00091	0.000917	CcSEcCtD
Glycopyrrolate—Pain in extremity—Doxorubicin—kidney cancer	0.00091	0.000917	CcSEcCtD
Glycopyrrolate—Flushing—Capecitabine—kidney cancer	0.000906	0.000913	CcSEcCtD
Glycopyrrolate—Cardiac disorder—Capecitabine—kidney cancer	0.000906	0.000913	CcSEcCtD
Glycopyrrolate—Asthenia—Sunitinib—kidney cancer	0.000903	0.00091	CcSEcCtD
Glycopyrrolate—Nausea—Vinblastine—kidney cancer	0.000898	0.000905	CcSEcCtD
Glycopyrrolate—Somnolence—Gemcitabine—kidney cancer	0.000897	0.000905	CcSEcCtD
Glycopyrrolate—Convulsion—Paclitaxel—kidney cancer	0.000897	0.000904	CcSEcCtD
Glycopyrrolate—Affect lability—Doxorubicin—kidney cancer	0.000895	0.000902	CcSEcCtD
Glycopyrrolate—Nausea—Everolimus—kidney cancer	0.000895	0.000902	CcSEcCtD
Glycopyrrolate—Hypertension—Paclitaxel—kidney cancer	0.000894	0.000901	CcSEcCtD
Glycopyrrolate—Pruritus—Sunitinib—kidney cancer	0.00089	0.000897	CcSEcCtD
Glycopyrrolate—Mediastinal disorder—Capecitabine—kidney cancer	0.00088	0.000887	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Dactinomycin—kidney cancer	0.000878	0.000884	CcSEcCtD
Glycopyrrolate—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000876	0.000883	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000872	0.000878	CcSEcCtD
Glycopyrrolate—Fatigue—Gemcitabine—kidney cancer	0.00087	0.000877	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Vincristine—kidney cancer	0.00087	0.000877	CcSEcCtD
Glycopyrrolate—Cardiac arrest—Doxorubicin—kidney cancer	0.000865	0.000872	CcSEcCtD
Glycopyrrolate—Dizziness—Sorafenib—kidney cancer	0.000865	0.000871	CcSEcCtD
Glycopyrrolate—Pain—Gemcitabine—kidney cancer	0.000863	0.00087	CcSEcCtD
Glycopyrrolate—Constipation—Gemcitabine—kidney cancer	0.000863	0.00087	CcSEcCtD
Glycopyrrolate—Nausea—Erlotinib—kidney cancer	0.000863	0.00087	CcSEcCtD
Glycopyrrolate—Dry mouth—Paclitaxel—kidney cancer	0.000862	0.000869	CcSEcCtD
Glycopyrrolate—Mood swings—Doxorubicin—kidney cancer	0.000862	0.000869	CcSEcCtD
Glycopyrrolate—Mental disorder—Capecitabine—kidney cancer	0.000855	0.000862	CcSEcCtD
Glycopyrrolate—Asthenia—Dactinomycin—kidney cancer	0.000855	0.000861	CcSEcCtD
Glycopyrrolate—Confusional state—Paclitaxel—kidney cancer	0.000852	0.000859	CcSEcCtD
Glycopyrrolate—Erythema—Capecitabine—kidney cancer	0.00085	0.000857	CcSEcCtD
Glycopyrrolate—Malnutrition—Capecitabine—kidney cancer	0.00085	0.000857	CcSEcCtD
Glycopyrrolate—Dehydration—Doxorubicin—kidney cancer	0.000846	0.000853	CcSEcCtD
Glycopyrrolate—Anaphylactic shock—Paclitaxel—kidney cancer	0.000845	0.000852	CcSEcCtD
Glycopyrrolate—Oedema—Paclitaxel—kidney cancer	0.000845	0.000852	CcSEcCtD
Glycopyrrolate—Body temperature increased—Vincristine—kidney cancer	0.000841	0.000848	CcSEcCtD
Glycopyrrolate—Abdominal pain—Vincristine—kidney cancer	0.000841	0.000848	CcSEcCtD
Glycopyrrolate—Infection—Paclitaxel—kidney cancer	0.00084	0.000846	CcSEcCtD
Glycopyrrolate—Flatulence—Capecitabine—kidney cancer	0.000837	0.000844	CcSEcCtD
Glycopyrrolate—Dry skin—Doxorubicin—kidney cancer	0.000834	0.00084	CcSEcCtD
Glycopyrrolate—Dysgeusia—Capecitabine—kidney cancer	0.000832	0.000839	CcSEcCtD
Glycopyrrolate—Dizziness—Sunitinib—kidney cancer	0.000832	0.000839	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Gemcitabine—kidney cancer	0.000832	0.000838	CcSEcCtD
Glycopyrrolate—Vomiting—Sorafenib—kidney cancer	0.000831	0.000838	CcSEcCtD
Glycopyrrolate—Nervous system disorder—Paclitaxel—kidney cancer	0.000829	0.000835	CcSEcCtD
Glycopyrrolate—Tachycardia—Paclitaxel—kidney cancer	0.000825	0.000831	CcSEcCtD
Glycopyrrolate—Rash—Sorafenib—kidney cancer	0.000824	0.000831	CcSEcCtD
Glycopyrrolate—Dermatitis—Sorafenib—kidney cancer	0.000824	0.00083	CcSEcCtD
Glycopyrrolate—Skin disorder—Paclitaxel—kidney cancer	0.000821	0.000827	CcSEcCtD
Glycopyrrolate—Headache—Sorafenib—kidney cancer	0.000819	0.000826	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Paclitaxel—kidney cancer	0.000817	0.000824	CcSEcCtD
Glycopyrrolate—Nasopharyngitis—Doxorubicin—kidney cancer	0.000813	0.00082	CcSEcCtD
Glycopyrrolate—Vision blurred—Capecitabine—kidney cancer	0.000801	0.000807	CcSEcCtD
Glycopyrrolate—Vomiting—Sunitinib—kidney cancer	0.0008	0.000806	CcSEcCtD
Glycopyrrolate—Body temperature increased—Gemcitabine—kidney cancer	0.000798	0.000804	CcSEcCtD
Glycopyrrolate—Rash—Sunitinib—kidney cancer	0.000793	0.0008	CcSEcCtD
Glycopyrrolate—Dermatitis—Sunitinib—kidney cancer	0.000793	0.000799	CcSEcCtD
Glycopyrrolate—Abdominal distension—Doxorubicin—kidney cancer	0.000792	0.000798	CcSEcCtD
Glycopyrrolate—Hypotension—Paclitaxel—kidney cancer	0.00079	0.000796	CcSEcCtD
Glycopyrrolate—Headache—Sunitinib—kidney cancer	0.000788	0.000794	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Vincristine—kidney cancer	0.000784	0.00079	CcSEcCtD
Glycopyrrolate—Nausea—Sorafenib—kidney cancer	0.000777	0.000783	CcSEcCtD
Glycopyrrolate—Insomnia—Paclitaxel—kidney cancer	0.000764	0.000771	CcSEcCtD
Glycopyrrolate—Asthenia—Vincristine—kidney cancer	0.000764	0.00077	CcSEcCtD
Glycopyrrolate—Vomiting—Dactinomycin—kidney cancer	0.000757	0.000763	CcSEcCtD
Glycopyrrolate—Somnolence—Paclitaxel—kidney cancer	0.000751	0.000757	CcSEcCtD
Glycopyrrolate—Palpitations—Capecitabine—kidney cancer	0.000751	0.000757	CcSEcCtD
Glycopyrrolate—Rash—Dactinomycin—kidney cancer	0.000751	0.000757	CcSEcCtD
Glycopyrrolate—Nausea—Sunitinib—kidney cancer	0.000747	0.000753	CcSEcCtD
Glycopyrrolate—Dyspepsia—Paclitaxel—kidney cancer	0.000744	0.00075	CcSEcCtD
Glycopyrrolate—Dysuria—Doxorubicin—kidney cancer	0.000735	0.000741	CcSEcCtD
Glycopyrrolate—Hypertension—Capecitabine—kidney cancer	0.000734	0.00074	CcSEcCtD
Glycopyrrolate—Upper respiratory tract infection—Doxorubicin—kidney cancer	0.000731	0.000737	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.00073	0.000735	CcSEcCtD
Glycopyrrolate—Fatigue—Paclitaxel—kidney cancer	0.000729	0.000734	CcSEcCtD
Glycopyrrolate—Asthenia—Gemcitabine—kidney cancer	0.000724	0.00073	CcSEcCtD
Glycopyrrolate—Pain—Paclitaxel—kidney cancer	0.000723	0.000728	CcSEcCtD
Glycopyrrolate—Constipation—Paclitaxel—kidney cancer	0.000723	0.000728	CcSEcCtD
Glycopyrrolate—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000719	0.000724	CcSEcCtD
Glycopyrrolate—Pruritus—Gemcitabine—kidney cancer	0.000714	0.00072	CcSEcCtD
Glycopyrrolate—Hyperglycaemia—Doxorubicin—kidney cancer	0.000709	0.000715	CcSEcCtD
Glycopyrrolate—Dry mouth—Capecitabine—kidney cancer	0.000708	0.000713	CcSEcCtD
Glycopyrrolate—Nausea—Dactinomycin—kidney cancer	0.000707	0.000713	CcSEcCtD
Glycopyrrolate—Pneumonia—Doxorubicin—kidney cancer	0.000705	0.000711	CcSEcCtD
Glycopyrrolate—Dizziness—Vincristine—kidney cancer	0.000704	0.000709	CcSEcCtD
Glycopyrrolate—Infestation NOS—Doxorubicin—kidney cancer	0.000701	0.000707	CcSEcCtD
Glycopyrrolate—Drowsiness—Doxorubicin—kidney cancer	0.000701	0.000707	CcSEcCtD
Glycopyrrolate—Infestation—Doxorubicin—kidney cancer	0.000701	0.000707	CcSEcCtD
Glycopyrrolate—Confusional state—Capecitabine—kidney cancer	0.000699	0.000705	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Paclitaxel—kidney cancer	0.000697	0.000702	CcSEcCtD
Glycopyrrolate—Oedema—Capecitabine—kidney cancer	0.000694	0.000699	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000691	0.000697	CcSEcCtD
Glycopyrrolate—Infection—Capecitabine—kidney cancer	0.000689	0.000695	CcSEcCtD
Glycopyrrolate—Urinary tract infection—Doxorubicin—kidney cancer	0.000681	0.000687	CcSEcCtD
Glycopyrrolate—Nervous system disorder—Capecitabine—kidney cancer	0.00068	0.000686	CcSEcCtD
Glycopyrrolate—Tachycardia—Capecitabine—kidney cancer	0.000677	0.000682	CcSEcCtD
Glycopyrrolate—Vomiting—Vincristine—kidney cancer	0.000677	0.000682	CcSEcCtD
Glycopyrrolate—Skin disorder—Capecitabine—kidney cancer	0.000674	0.000679	CcSEcCtD
Glycopyrrolate—Sweating—Doxorubicin—kidney cancer	0.000672	0.000677	CcSEcCtD
Glycopyrrolate—Urticaria—Paclitaxel—kidney cancer	0.000671	0.000677	CcSEcCtD
Glycopyrrolate—Rash—Vincristine—kidney cancer	0.000671	0.000676	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Capecitabine—kidney cancer	0.000671	0.000676	CcSEcCtD
Glycopyrrolate—Dermatitis—Vincristine—kidney cancer	0.00067	0.000676	CcSEcCtD
Glycopyrrolate—Body temperature increased—Paclitaxel—kidney cancer	0.000668	0.000673	CcSEcCtD
Glycopyrrolate—Abdominal pain—Paclitaxel—kidney cancer	0.000668	0.000673	CcSEcCtD
Glycopyrrolate—Headache—Vincristine—kidney cancer	0.000667	0.000672	CcSEcCtD
Glycopyrrolate—Epistaxis—Doxorubicin—kidney cancer	0.000661	0.000666	CcSEcCtD
Glycopyrrolate—Sinusitis—Doxorubicin—kidney cancer	0.000658	0.000663	CcSEcCtD
Glycopyrrolate—Hypotension—Capecitabine—kidney cancer	0.000648	0.000653	CcSEcCtD
Glycopyrrolate—Vomiting—Gemcitabine—kidney cancer	0.000642	0.000647	CcSEcCtD
Glycopyrrolate—Rash—Gemcitabine—kidney cancer	0.000637	0.000642	CcSEcCtD
Glycopyrrolate—Dermatitis—Gemcitabine—kidney cancer	0.000636	0.000641	CcSEcCtD
Glycopyrrolate—Headache—Gemcitabine—kidney cancer	0.000632	0.000637	CcSEcCtD
Glycopyrrolate—Nausea—Vincristine—kidney cancer	0.000632	0.000637	CcSEcCtD
Glycopyrrolate—Rhinitis—Doxorubicin—kidney cancer	0.000631	0.000636	CcSEcCtD
Glycopyrrolate—Insomnia—Capecitabine—kidney cancer	0.000627	0.000632	CcSEcCtD
Glycopyrrolate—Hypoaesthesia—Doxorubicin—kidney cancer	0.000626	0.000631	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Paclitaxel—kidney cancer	0.000623	0.000628	CcSEcCtD
Glycopyrrolate—Urinary tract disorder—Doxorubicin—kidney cancer	0.000622	0.000626	CcSEcCtD
Glycopyrrolate—Connective tissue disorder—Doxorubicin—kidney cancer	0.000618	0.000623	CcSEcCtD
Glycopyrrolate—Urethral disorder—Doxorubicin—kidney cancer	0.000617	0.000622	CcSEcCtD
Glycopyrrolate—Dyspepsia—Capecitabine—kidney cancer	0.000611	0.000615	CcSEcCtD
Glycopyrrolate—Asthenia—Paclitaxel—kidney cancer	0.000606	0.000611	CcSEcCtD
Glycopyrrolate—Nausea—Gemcitabine—kidney cancer	0.0006	0.000604	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000599	0.000604	CcSEcCtD
Glycopyrrolate—Fatigue—Capecitabine—kidney cancer	0.000598	0.000603	CcSEcCtD
Glycopyrrolate—Pruritus—Paclitaxel—kidney cancer	0.000598	0.000603	CcSEcCtD
Glycopyrrolate—Pain—Capecitabine—kidney cancer	0.000593	0.000598	CcSEcCtD
Glycopyrrolate—Constipation—Capecitabine—kidney cancer	0.000593	0.000598	CcSEcCtD
Glycopyrrolate—Flushing—Doxorubicin—kidney cancer	0.000584	0.000589	CcSEcCtD
Glycopyrrolate—Cardiac disorder—Doxorubicin—kidney cancer	0.000584	0.000589	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Capecitabine—kidney cancer	0.000572	0.000576	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Capecitabine—kidney cancer	0.000567	0.000572	CcSEcCtD
Glycopyrrolate—Mediastinal disorder—Doxorubicin—kidney cancer	0.000567	0.000572	CcSEcCtD
Glycopyrrolate—Dizziness—Paclitaxel—kidney cancer	0.000559	0.000563	CcSEcCtD
Glycopyrrolate—Mental disorder—Doxorubicin—kidney cancer	0.000551	0.000556	CcSEcCtD
Glycopyrrolate—Urticaria—Capecitabine—kidney cancer	0.000551	0.000555	CcSEcCtD
Glycopyrrolate—Abdominal pain—Capecitabine—kidney cancer	0.000548	0.000553	CcSEcCtD
Glycopyrrolate—Body temperature increased—Capecitabine—kidney cancer	0.000548	0.000553	CcSEcCtD
Glycopyrrolate—Malnutrition—Doxorubicin—kidney cancer	0.000548	0.000552	CcSEcCtD
Glycopyrrolate—Erythema—Doxorubicin—kidney cancer	0.000548	0.000552	CcSEcCtD
Glycopyrrolate—Flatulence—Doxorubicin—kidney cancer	0.00054	0.000544	CcSEcCtD
Glycopyrrolate—CHRM3—renal system—kidney cancer	0.000538	0.0687	CbGeAlD
Glycopyrrolate—Tension—Doxorubicin—kidney cancer	0.000538	0.000542	CcSEcCtD
Glycopyrrolate—Vomiting—Paclitaxel—kidney cancer	0.000537	0.000542	CcSEcCtD
Glycopyrrolate—Dysgeusia—Doxorubicin—kidney cancer	0.000536	0.000541	CcSEcCtD
Glycopyrrolate—Rash—Paclitaxel—kidney cancer	0.000533	0.000537	CcSEcCtD
Glycopyrrolate—Dermatitis—Paclitaxel—kidney cancer	0.000532	0.000537	CcSEcCtD
Glycopyrrolate—Nervousness—Doxorubicin—kidney cancer	0.000532	0.000536	CcSEcCtD
Glycopyrrolate—Headache—Paclitaxel—kidney cancer	0.00053	0.000534	CcSEcCtD
Glycopyrrolate—CHRM3—kidney—kidney cancer	0.00052	0.0664	CbGeAlD
Glycopyrrolate—Vision blurred—Doxorubicin—kidney cancer	0.000516	0.00052	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Capecitabine—kidney cancer	0.000511	0.000515	CcSEcCtD
Glycopyrrolate—Agitation—Doxorubicin—kidney cancer	0.000503	0.000507	CcSEcCtD
Glycopyrrolate—Nausea—Paclitaxel—kidney cancer	0.000502	0.000506	CcSEcCtD
Glycopyrrolate—Asthenia—Capecitabine—kidney cancer	0.000498	0.000502	CcSEcCtD
Glycopyrrolate—Pruritus—Capecitabine—kidney cancer	0.000491	0.000495	CcSEcCtD
Glycopyrrolate—Palpitations—Doxorubicin—kidney cancer	0.000484	0.000488	CcSEcCtD
Glycopyrrolate—Convulsion—Doxorubicin—kidney cancer	0.000475	0.000478	CcSEcCtD
Glycopyrrolate—Hypertension—Doxorubicin—kidney cancer	0.000473	0.000477	CcSEcCtD
Glycopyrrolate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	0.000463	0.000467	CcSEcCtD
Glycopyrrolate—Dizziness—Capecitabine—kidney cancer	0.000459	0.000462	CcSEcCtD
Glycopyrrolate—Dry mouth—Doxorubicin—kidney cancer	0.000456	0.00046	CcSEcCtD
Glycopyrrolate—Confusional state—Doxorubicin—kidney cancer	0.000451	0.000454	CcSEcCtD
Glycopyrrolate—Anaphylactic shock—Doxorubicin—kidney cancer	0.000447	0.000451	CcSEcCtD
Glycopyrrolate—Oedema—Doxorubicin—kidney cancer	0.000447	0.000451	CcSEcCtD
Glycopyrrolate—Infection—Doxorubicin—kidney cancer	0.000444	0.000448	CcSEcCtD
Glycopyrrolate—Vomiting—Capecitabine—kidney cancer	0.000441	0.000444	CcSEcCtD
Glycopyrrolate—Nervous system disorder—Doxorubicin—kidney cancer	0.000438	0.000442	CcSEcCtD
Glycopyrrolate—Rash—Capecitabine—kidney cancer	0.000437	0.000441	CcSEcCtD
Glycopyrrolate—Dermatitis—Capecitabine—kidney cancer	0.000437	0.00044	CcSEcCtD
Glycopyrrolate—Tachycardia—Doxorubicin—kidney cancer	0.000436	0.00044	CcSEcCtD
Glycopyrrolate—Headache—Capecitabine—kidney cancer	0.000435	0.000438	CcSEcCtD
Glycopyrrolate—Skin disorder—Doxorubicin—kidney cancer	0.000434	0.000438	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Doxorubicin—kidney cancer	0.000432	0.000436	CcSEcCtD
Glycopyrrolate—Hypotension—Doxorubicin—kidney cancer	0.000418	0.000421	CcSEcCtD
Glycopyrrolate—Nausea—Capecitabine—kidney cancer	0.000412	0.000415	CcSEcCtD
Glycopyrrolate—Insomnia—Doxorubicin—kidney cancer	0.000404	0.000408	CcSEcCtD
Glycopyrrolate—Somnolence—Doxorubicin—kidney cancer	0.000397	0.000401	CcSEcCtD
Glycopyrrolate—Dyspepsia—Doxorubicin—kidney cancer	0.000394	0.000397	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.000386	0.000389	CcSEcCtD
Glycopyrrolate—Fatigue—Doxorubicin—kidney cancer	0.000385	0.000389	CcSEcCtD
Glycopyrrolate—Pain—Doxorubicin—kidney cancer	0.000382	0.000385	CcSEcCtD
Glycopyrrolate—Constipation—Doxorubicin—kidney cancer	0.000382	0.000385	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Doxorubicin—kidney cancer	0.000368	0.000371	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Doxorubicin—kidney cancer	0.000366	0.000368	CcSEcCtD
Glycopyrrolate—Urticaria—Doxorubicin—kidney cancer	0.000355	0.000358	CcSEcCtD
Glycopyrrolate—Body temperature increased—Doxorubicin—kidney cancer	0.000353	0.000356	CcSEcCtD
Glycopyrrolate—Abdominal pain—Doxorubicin—kidney cancer	0.000353	0.000356	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Doxorubicin—kidney cancer	0.000329	0.000332	CcSEcCtD
Glycopyrrolate—Asthenia—Doxorubicin—kidney cancer	0.000321	0.000323	CcSEcCtD
Glycopyrrolate—Pruritus—Doxorubicin—kidney cancer	0.000316	0.000319	CcSEcCtD
Glycopyrrolate—Dizziness—Doxorubicin—kidney cancer	0.000296	0.000298	CcSEcCtD
Glycopyrrolate—Vomiting—Doxorubicin—kidney cancer	0.000284	0.000287	CcSEcCtD
Glycopyrrolate—Rash—Doxorubicin—kidney cancer	0.000282	0.000284	CcSEcCtD
Glycopyrrolate—Dermatitis—Doxorubicin—kidney cancer	0.000282	0.000284	CcSEcCtD
Glycopyrrolate—Headache—Doxorubicin—kidney cancer	0.00028	0.000282	CcSEcCtD
Glycopyrrolate—Nausea—Doxorubicin—kidney cancer	0.000266	0.000268	CcSEcCtD
